j.petrov
TL2 · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 9 July 2025 · last posted 13h · groups: translators
86 posts, newest first. Showing up to 150.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #76 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 32 likes On Detection wavelength, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
The anatomy of a question that gets answered within an hour Replied, post #124 · Start Here › How to Ask · 24 Jul 2026 · 7 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop. That holds for the case as described.…
-
Immortal time bias in a claims-database study — one year on Replied, post #30 · Evidence › Study critique · 18 Jul 2026 · 24 likes Where I part company with post #27, and it is a narrow parting. On Immortal time bias the community has more anecdote than the confidence in this thread implies, and I…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #43 · Compounds › Secretagogues & GH axis · 16 Jul 2026 · 12 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #23 · Practice › Administration · 3 Jul 2026 · 31 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #91 · Start Here › How to Ask · 2 Jul 2026 · 3 likes Worth separating two things that post #89 runs together. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers…
-
Spreadsheets: an appreciation — what changed since Replied, post #88 · Lounge › Off topic · 2 Jul 2026 · 10 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute. The part I am sure of…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #74 · Start Here › How to Ask · 26 Jun 2026 · 8 likes Building on post #71 rather than restating it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post…
-
The headache that turns out to be dehydration — the long version Replied, post #51 · Nutrition & Training › Hydration & electrolytes · 15 Jun 2026 · 21 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #73 · Compounds › Semaglutide · 7 Jun 2026 · 1 like The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Request: a per-category review queue Replied, post #19 · Meta › Feature requests · 4 Jun 2026 · 27 likes Adding the measurement that post #17 says would settle it. I have been on both sides of the per-category review queue argument in this category within eighteen months,…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #14 · Research Methods › Statistics · 3 Jun 2026 · 20 likes Rounding and significant figures carry information about precision. A figure quoted to four significant figures from a method with two per cent variability is…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #60 · Devices › Syringes & needles · 3 Jun 2026 · 11 likes Post #58 and I disagree about the size of the effect, not about the direction. Sharps containers are a legal requirement for disposal in several jurisdictions and a…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #9 · marked as the solution · Compounds › Tirzepatide · 31 May 2026 · 27 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
Blind submission and why it changes minds — the long version Replied, post #90 · Sourcing › Independent verification · 22 May 2026 · 2 likes Adding what did not work for me on Blind submission, since the failures never get written up and they are half the useful information.
-
Reused chromatograms across lots: how to spot it Replied, post #42 · Analytics › COA interpretation · 17 May 2026 · 5 likes I read post #40 twice before replying, because I had assumed the opposite. I have been on both sides of the reused chromatograms across lots argument in this category…
-
Batch numbers that do not match the vial label — what changed since Replied, post #12 · Sourcing › Red flags · 12 May 2026 · 31 likes The practical version of Batch numbers is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Journal club: is percentage weight change the right endpoint? Replied, post #112 · Evidence › Journal club · 28 Apr 2026 · 19 likes Picking up post #109: that is the part I would want checked first. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
-
Mood changes: monitoring, and when to involve a professional — what changed since Replied, post #8 · Wellbeing › Mental health · 21 Apr 2026 · 0 likes Building on post #6 rather than restating it. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk.…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #110 · Clinical › Special populations · 14 Apr 2026 · 0 likes This follows post #109 rather than contradicting it. Genetic and ancestry-related differences in response are asked about regularly and the published evidence is thin…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #77 · Analytics › Mass spectrometry · 13 Apr 2026 · 25 likes Distinguishing three things in the Charge states discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #89 · Practice › Dosing & titration · 9 Apr 2026 · 27 likes That reframing is the whole thing. The facts I already had.
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #17 · Practice › Administration · 2 Apr 2026 · 2 likes Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting one area changes the local tissue over time and eventually changes…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #19 · Evidence › Preprints · 28 Mar 2026 · 7 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. I would be interested…
-
The anatomy of a question that gets answered within an hour Replied, post #2 · Start Here › How to Ask · 20 Mar 2026 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. The specific question in the title is more useful than you might think. A…
-
Amylin receptor signalling and satiety — what changed since Replied, post #36 · Pharmacology › Receptor biology · 26 Feb 2026 · 0 likes The C-cell finding in rodent toxicology is a receptor-biology observation with a species-specific interpretation. It is the reason for a specific contraindication…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #17 · Start Here › Welcome · 24 Feb 2026 · 28 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #52 · Clinical › Special populations · 23 Feb 2026 · 25 likes Post #49 answers the question as asked. The question underneath it is different. Genetic and ancestry-related differences in response are asked about regularly and the…
-
Measurement error in a self-reported exposure Replied, post #27 · Evidence › Study critique · 23 Feb 2026 · 0 likes The useful distinction on measurement error is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…
-
[2026 update] What a purity-only report leaves out Replied, post #33 · Sourcing › Independent verification · 23 Feb 2026 · 19 likes What I want from this purity-only thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #8 · Analytics › Method validation · 19 Feb 2026 · 19 likes Everything in post #4 holds. The case it does not cover is the one I have. Transfer between laboratories: a method can be transferred from one lab to another, but the…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #33 · Evidence › Trials · 19 Feb 2026 · 28 likes Practical answer on Non-inferiority margins, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #33 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #103 · Access › International · 11 Feb 2026 · 10 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #143 · Documentation › Doc review · 30 Jan 2026 · 0 likes Answering the question post #139 raises rather than the one it answers. The most useful review comment names a sentence and says what is wrong with it. General approval…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #82 · Clinical › Special populations · 25 Jan 2026 · 30 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done.
-
DXA precision and the least significant change for lean mass Replied, post #60 · Outcomes › Body composition · 11 Dec 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #84 · Practice › Reconstitution · 26 Nov 2025 · 0 likes Building on post #81 rather than restating it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working…
-
Lurking for two months before posting: was that the right call? Replied, post #68 · Start Here › Welcome · 21 Nov 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Pen dose counters: what a click does and does not guarantee Replied, post #116 · Devices › Pens & autoinjectors · 20 Nov 2025 · 5 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Long-time reader, first-time poster Replied, post #9 · Lounge › Introductions · 8 Nov 2025 · 7 likes This is the sort of exchange that makes the archive worth searching.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #55 · Start Here › How to Ask · 3 Nov 2025 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Not the answer, but possibly the…
-
Sleep tracking data and its considerable limitations Replied, post #102 · Wellbeing › Sleep · 27 Oct 2025 · 0 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher. That…
-
Sleep quality changes during weight loss — what changed since Replied, post #40 · Wellbeing › Sleep · 26 Oct 2025 · 0 likes Nothing here is medical advice, and suspected sleep-disordered breathing specifically is something to have assessed properly rather than tracked.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #44 · Lounge › Off topic · 19 Sep 2025 · 2 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Substitution between formats during a shortage Replied, post #53 · Access › Shortages · 8 Sep 2025 · 3 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
-
A ten-fold dose error caught before injection Replied, post #93 · Devices › Syringes & needles · 3 Sep 2025 · 0 likes Post #92 is right about the mechanism and I think understates the practical bit. Reusing a needle blunts it and there is no benefit to offset that. The second injection…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #58 · Evidence › Journal club · 29 Aug 2025 · 0 likes Building on post #57 rather than restating it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3)…
-
Pooling trials with different estimands — what changed since Replied, post #15 · Evidence › Meta-analyses · 20 Aug 2025 · 28 likes Fixed-effect and random-effects models answer different questions. The first assumes one true effect; the second assumes a distribution of them. Choosing between them…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #42 · Practice › Reconstitution · 11 Aug 2025 · 1 like Reporting rather than recommending, on Over-dilution. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #106 · Practice › Storage & stability · 6 Aug 2025 · 28 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #50 · Evidence › Journal club · 13 Jun 2025 · 2 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2025 · 20 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 10 Jun 2025 · 28 likes Adding the measurement that post #55 says would settle it. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
-
Revisiting: German, French and Dutch differences, compared Replied, post #24 · Regional › European Union · 21 May 2025 · 4 likes Answering the question post #20 raises rather than the one it answers. Date every claim. Positions in this subcategory have moved repeatedly and the archive keeps posts…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #91 · Wellbeing › Mental health · 21 May 2025 · 29 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
A report I filed that turned out to be wrong, and the correction Replied, post #49 · Sourcing › Vendor reports · 11 May 2025 · 0 likes On post #47 — agreed on the reasoning, with one qualification. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate…
-
When to stop reading forums, including this one — the long version Replied, post #10 · Wellbeing › Mental health · 5 May 2025 · 11 likes The most useful posts in this subcategory are specific about what helped, including the ordinary things that sound too simple to mention. The variance between people…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #25 · Evidence › Journal club · 10 Apr 2025 · 24 likes Post #24 is right about the mechanism and I think understates the practical bit. I have been on both sides of the retatrutide phase 2 obesity paper argument in this…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #108 · Compounds › Cagrilintide & amylin analogues · 4 Apr 2025 · 15 likes Taking cagrilintide alone seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #28 · Wellbeing › Mental health · 3 Apr 2025 · 27 likes One caution on history of disordered eating: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #87 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 7 likes I read post #86 twice before replying, because I had assumed the opposite. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a…
-
Reading a supplier's product description as a marketing document Replied, post #7 · Compounds › Other compounds · 24 Mar 2025 · 15 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #84 · Compounds › Semaglutide · 2 Mar 2025 · 0 likes Where I part company with post #80, and it is a narrow parting. For anyone finding this later: the short answer on published dose-response for semaglutide is that it…
-
Charge states for a 4 kDa peptide, worked through Started this topic · Analytics › Mass spectrometry · 28 Feb 2025 · 4 likes On the subject in the title: Charge states for a 4 kDa peptide, worked through Working notes rather than a conclusion. Working through the identity arithmetic and I…
-
Consistent declarations and why they matter more than clever ones Replied, post #37 · Sourcing › Logistics · 15 Feb 2025 · 29 likes My experience of consistent declarations contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 11 Feb 2025 · 22 likes That is a cleaner way of putting what I was circling around.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #31 · Evidence › Journal club · 3 Feb 2025 · 9 likes Taking post #28 at face value and following it one step further. What I would check first on STEP 4 is whether the thing being measured moved or whether the way of…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #31 · Devices › Cold chain · 4 Jan 2025 · 5 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #97 · Compounds › Oral incretins · 28 Dec 2024 · 3 likes Adding the measurement that post #96 says would settle it. Before the thread moves on from Oral semaglutide bioavailability — what is the sample size behind the claim?…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #72 · Compounds › Oral incretins · 27 Dec 2024 · 21 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Reading a supplementary appendix and finding the interesting part Replied, post #46 · Evidence › Trials · 17 Dec 2024 · 20 likes The strongest argument against my own position on reading a supplementary appendix, stated as well as I can state it, since nobody else has yet.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #61 · Nutrition & Training › Protein & intake · 16 Dec 2024 · 12 likes An update on my earlier Meeting a protein target post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Turnaround times and what they mean for a decision — one year on Replied, post #18 · Sourcing › Independent verification · 1 Dec 2024 · 12 likes The most useful reply I ever got about Turnaround times was a request to state my units. It sounds like pedantry and it has saved me twice.
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #6 · Evidence › Trials · 28 Nov 2024 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #43 · Meta › Wiki maintenance · 21 Nov 2024 · 14 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #12 · Nutrition & Training › Resistance training · 8 Nov 2024 · 0 likes The practical version of Recovery is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #22 · Compounds › Tirzepatide · 4 Nov 2024 · 0 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
Hello from a laboratory that does not do peptides — does this still hold? Started this topic · Lounge › Introductions · 3 Nov 2024 · 60 likes Asking directly, because I could not find a straight answer: Hello from a laboratory that does not do peptides — does this still hold? Saying hello, and stating my…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #78 · Compounds › Other compounds · 28 Oct 2024 · 22 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #91 · Nutrition & Training › Hydration & electrolytes · 13 Sep 2024 · 0 likes Taking post #90 at face value and following it one step further. My understanding of Sodium is a few years old and may have been superseded. If it has been, I would…
-
Renal impairment: what the labelling says about dose Replied, post #2 · Clinical › Special populations · 15 Aug 2024 · 10 likes Everything in the opening post holds. The case it does not cover is the one I have. Where a labelling document addresses a population explicitly, that text is the…
-
Circumference measurements as a poor man's composition estimate Replied, post #25 · Outcomes › Body composition · 28 Jul 2024 · 12 likes My understanding of circumference measurements is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
Guidelines revision: what changed and why Replied, post #51 · Meta › Announcements · 26 Jul 2024 · 19 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #27 · Compounds › Retatrutide · 17 Jul 2024 · 0 likes Coming back to post #23, because the follow-up matters more than the original answer. Retatrutide dose escalation is one of those subjects where the general answer and…
-
How this community labels and discusses unrefereed work Replied, post #45 · Evidence › Preprints · 27 Jun 2024 · 15 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…